Adamant Ventures joins others in £10m Serentis investment
Adamant Ventures has joined existing investors in the £10m (EUR12.5m) second tranche of a first round of funding for Cambridge-based biopharma group Serentis.
MVM
Adamant Ventures has joined existing investors in the £10m (EUR12.5m) second tranche of a first round of funding for Cambridge-based biopharma group Serentis.
MVM